HCPC
TMO icon

Hamilton Capital Partners (Canada)’s Thermo Fisher Scientific TMO Stock Holding History

Hamilton Capital Partners (Canada)’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.84M Buy
15,630
+2,275
+17% +$1.09M 0.23% 78
2026
Q1 		$6.56M Buy
13,355
+2,449
+22% +$1.33M 0.22% 73
2025
Q4 		$6.32M Buy
10,906
+966
+10% +$546K 0.23% 80
2025
Q3 		$4.82M Buy
9,940
+124
+1% +$57.7K 0.2% 91
2025
Q2 		$3.98M Buy
9,816
+2,134
+28% +$892K 0.2% 93
2025
Q1 		$3.82M Buy
7,682
+1,242
+19% +$673K 0.25% 92
2024
Q4 		$3.35M Sell
6,440
-744
-10% -$409K 0.25% 85
2024
Q3 		$4.44M Sell
7,184
-927
-11% -$549K 0.38% 62
2024
Q2 		$4.49M Buy
8,111
+450
+6% +$258K 0.48% 66
2024
Q1 		$4.45M Buy
+7,661
New +$4.3M 0.54% 68

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Hamilton Capital Partners (Canada)'s TMO Position: Q2 2026 in Review

Hamilton Capital Partners (Canada) increased its Thermo Fisher Scientific (TMO) stake by 17% in Q2 2026, buying an estimated $1.09M and bringing the position to 15,630 shares worth $7.84M. The position accounts for 0.23% of the portfolio, ranked #78.

Hamilton Capital Partners (Canada) first reported a position in TMO in Q1 2024 and has held it in 10 quarters since. 2,508 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Hamilton Capital Partners (Canada) held 15,630 shares of Thermo Fisher Scientific worth $7.84M as of Q2 2026.
  • Hamilton Capital Partners (Canada) bought 2,275 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.09M.
  • Thermo Fisher Scientific made up 0.23% of Hamilton Capital Partners (Canada)'s portfolio in Q2 2026, its #78 holding.
  • Hamilton Capital Partners (Canada) first reported a position in Thermo Fisher Scientific in Q1 2024 and has held it in 10 quarters since.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Hamilton Capital Partners (Canada)'s 13F filing for Q2 2026, filed 14 Aug 2026.